Residency Program Director
Melissa Snider, PharmD, BCPS, CLS, BCACP
- Manager and Specialty Practice Pharmacist, Ambulatory Care
- Clinical Assistant Professor, The OSU College of Pharmacy
- PGY2 Ambulatory Care Residency Program Director
- PharmD- Ohio Northern Univeristy
- PGY1 Veterans Affairs Medical Center
Previous Year Residents
Alyssa RinaldiPursing interest in Ambulatory Care
Allyson HelmsClinical Pharmacist Specialist, Complete Endocrinology Clinic/Cardiometabolic Center/Primary Care Clinics, Bryan Health, Lincoln, NE
Nicole ThomasClinical Pharmacy Specialist, Ambulatory Care, University of Cincinnati
Katharine LundyClinical Pharmacist, Franciscan Health, Olympia Fields, IL
Caitlin MillsSpecialty Practice Clinical Pharmacist, The Ohio State University Wexner Medical Center
Erika TopClinical Pharmacist, Neurology, Northwell Health
Tara NagarajAmbulatory care pharmacist, Saint Elizabeth Healthcare, Kentucky
Hannah RhinehartAmbulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
Elisa BaddourPrimary Care Clinical Specialist position at the Cleveland Clinic
Megan BorchersAmbulatory Care Specialty Practice Pharmacist, St. Elizabeth Healthcare in Northern Kentucky
Adam IngramAmbulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
Lindsey MestonClinical Pharmacist, Chronic Care Management and Transitions of Care Services, Asti's Pharmacy, Pittsburgh
Erica DavidsonAmbulatory Care Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center
Marie WaddlesAmbulatory Care Clinical Pharmacy Specialist, WakeMed Hospital, Raleigh, North Carolina, & Assistant Professor of Clinical Pharmacy, UNC Eshelman School of Pharmacy
Abby RabatinAmbulatory Care Specialty Practice Pharmacist at The Ohio State University Wexner Medical Center
Elise AlbroAmbulatory Care Specialty Practice Pharmacist at The Ohio State University Wexner Medical Center
About the PGY2 Ambulatory Care – Wexner Medical Center Residency Program
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in that practice area (when board certification for the practice area exists).
PGY2 at Wexner Medical Center residency graduates are primed for ambulatory practice as an independent clinical specialist within pharmacy-run clinics, and for ambulatory leadership, teaching, and research. Not only will the residents develop the ability to treat and appropriately triage the most complex chronic and acute illnesses presented by ambulatory patients, but also will have the ability to manage operational aspects of ambulatory care, to expand/develop innovative programs or services that contribute to the public’s health, and to participate in professional organizations.
In addition, the leadership, research, and presentation skills of graduates equips them to serve the ambulatory practice as experts on development and expansion of services, participating in and completing research and quality improvement projects, delivering medication management therapy, and sustainability of pharmacy services to outpatients. The residents will also demonstrate an advanced capability to provide insightful education or training for students, pharmacy residents, pharmacy colleagues, nurses, and physicians.
The PGY2 Ambulatory Care resident will practice within the OSUWMC Health-System, including hospital based clinics within the Richard M. Ross Heart Hospital, a leader in cardiovascular care, as well as several non-hospital based clinics within OSU Carepoint centers. The pharmacist-driven ambulatory care clinics operate under collaborative practice agreements. Ambulatory Care Specialty Pharmacists are privileged by the institution and involved in many areas of patient care including anticoagulation management, cardiovascular risk reduction, medication therapy management, hep C medications, and smoking cessation services.
The PGY2 Ambulatory Care Residency at The Ohio State University Wexner Medical Center combines clinical, administrative, and project management experiences in various specialized areas. The residency provides a well-rounded experience to help develop the resident’s clinical and operational expertise. The resident becomes a core member of the Ambulatory Care Pharmacy team through structured rotation experiences and projects. The resident will be encouraged to seek opportunities in their areas of interest.Read about the sites
As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care. OSUWMC is a 1,506 bed multihospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.
University Hospital (UH)
University Hospital (UH) is our flagship hospital with over 900 beds. UH is a major referral center for patients throughout Ohio and the Midwest, and is one of the busiest kidney and pancreas transplant centers in the world. UH is also an international center for neuromodulation research and neurological care. In addition, UH is a level 1 trauma center in addition to being the primary burn center for the region. The James Cancer Hospital and Solove Research Institute is one of the nation’s premier centers for the prevention, detection and treatment of cancer.
OSUWMC features the world’s most advanced cancer and critical care hospital which opened in December of 2014. With the opening of the new hospital, our institution boasts an Emergency Department (ED) with over 100 beds and an area dedicated specifically to the care of cancer patients within the ED. Medical Intensive Care, Surgical Intensive Care, Neuro Intensive Care, and Cancer specific ICU patient care areas also exist within the new critical care tower.
The Ross Heart Hospital
The Ross Heart Hospital is a leader in cardiology and heart surgery and is the only nationally ranked heart hospital in the area. Each floor of the 150-bed hospital is dedicated to a specific service, which helps us provide specialized care for every patient. The Ross is one of the largest centers for the implantation of LVAD devices in the world in addition to providing heart and lung transplants.
University Hospitals East
University Hospitals East (UHE) blends the friendly atmosphere of a community hospital with the advantages of being a part of a major academic medical center. Located on the eastern edge of downtown Columbus, University Hospital East offers renowned Ohio State services in orthopedic care, emergency services, cancer care, addiction services, ear, nose and throat care, heart care, radiology and imaging services, rehabilitation and wound healing.
OSU Ancillary Sites: Carepoint Gahanna, Carepoint East and Ohio State Outpatient Care Upper Arlington
These sites provide high-quality and conveniently located health services with an emphasis on prevention of disease and illness, as well as the treatment of routine and complex medical conditions across the spectrum of one’s life.
Central Ohio Primary Care (COPC)
COPC is the largest physician-owned primary care medical group in the United States with over 300 providers and 55 practice locations throughout central Ohio.
The Brain and Spine Hospital
The Brain and Spine Hospital opened in the Fall of 2016 and is a state-of-the-art facility for the advanced management, care and healing of patients with neurological disorders.The hospital consists of 87 private beds and specialized units for stroke and neurovascular, neurotrauma, epilipsy, spine, chronic pain, neuromodulaton, multiple sclerosis, congnitive and movement disorders, as well as an innovative new model for acute spinal cord injuries.
The Department of Pharmacy
The Department of Pharmacy at The OSUWMC is one of the largest in the country. With over 400 employees, and a practice model that includes both clinical pharmacy generalists and clinical pharmacy specialists, our goal is the provision of outstanding, state of the art care. We advise our staff on the best use of medications, develop safeguards for our patients to prevent medication errors and develop transformative pharmacy practice in health-systems.
We are guided in this mission by our strategic plan that focuses on five key priorities: optimizing our pharmacy information system, refining our practice model, enhancing our medication safety program, establishing the pharmacy as a workplace of choice in Central Ohio and refining our academic relationships and department scholarship. Training future generations of pharmacists is a vital part of our mission. Our pharmacists serve as preceptors for our residency programs while providing experiential training for Doctor of Pharmacy (PharmD) students.
Our residency program has a 55-year tradition of excellence with our graduates being well-prepared to work at a high-level in a wide-variety of institutional and ambulatory patient care facilities. The Department of Pharmacy, in partnership with the OSU College of Pharmacy, strives to develop the skills of our residents and provide a residency program that is recognized nationally for the quality and Ohio State University Wexner Medical Center.
Rotational experiences for the Wexner Medical Center (WMC) PGY2 residency in ambulatory care are designed to provide the resident with an exposure to a variety of ambulatory pharmacy services and patient populations. One of the most notable features of the PGY2 Ambulatory Care residency at the OSUWMC is the wide variety of rotation options and flexibility in scheduling and customization to individual interests.Read More
The resident is required to complete one orientation month. Within the first three months, the resident is strongly encouraged to complete a one month acute care cardiology rotation to increase exposure to core inpatient and transition of care concepts. The remainder of the experiences are longitudinal and a mix of core and elective. The length of electives vary, therefore a resident’s number of electives can also vary. Residents typically spend 5-6 half days weekly in direct patient care. Rotation selections will be guided by the Residency Program Director, and will ensure that the resident achieves a broad range of experiences and exposure to various patient populations.
Other key experiences during the residency will include the completion of a major research project, the completion of a quality improvement project, completion of an administrative ambulatory project, participation in a resident research series, delivery of 6 informal noon conferences and 1 formal educational lecture, and development or expansion of clinical pharmacy services. The resident will also have the opportunity to attend the ASHP Midyear Clinical Meeting in addition to presenting their finalized research project at a Pharmacy Residency Conference.
- Ambulatory Pharmacy Administration
- Antiarrhythmic Medication Monitoring
- Anticoagulation Management Service
- Hepatitis C Medications
- Lipid Management/Cardiovascular Risk Reduction
- Primary Care
- Smoking Cessation Clinic
- Acute Care Cardiology*
- Internal Medicine
- Diabetes Management
- Emergency Medicine
- Heart Failure
- Infectious Diseases
- Medication Assistance
- Medication Therapy Management
- Ohio Pre-operative Assessment Clinic (OPAC)
- Pain Management
- Resistant Hypertension
- Solid Organ Transplant Clinic
- Transitions of Care
- Additional opportunities exist based on interests
Melissa Snider, PharmD, BCPS,
Elise Albro, PharmD, MPA, TTS, BCACP
Kelly Bartsch, PharmD, BCPS, CLS
Erica Davidson, PharmD, BCACP
Margie Hevezi, PharmD, CDE, CLS
Sarah Hill, PharmD, BCPS
Amy James, PharmD, BCACP, CACP, BC-ADM
Maggie Ladlie, PharmD, BCACP
Kim Niver, PharmD, BCACP
Tiffany Ortman, PharmD, BCACP, CACP
Maria Pruchnicki, PharmD, BCPS, CLS, BCACP
Abigail Rabatin, PharmD, BCACP, CLS
Diana Venci, PharmD, BCPS, CLS, CGP
Selected Resident Research
- Evaluation of an interdisciplinary transitions-of-care program for Medicare Advantage patients of a physician-owned medical group – Baddour E, Snider M, Minaudo J, Blosser L.
- Bleeding risks for patients on chronic anticoagulation undergoing cardiac implantable electronic device (CIED) extraction – Borchers M, Snider M, Boyd M, Vinh D, Houmsse M.
- Comparison of Pharmacist-Managed Anticoagulation Service Models in Patients with Continuous Flow Ventricular Assist Devices – Ingram A, Ortman T, Snider M, Hevezi M, Weiss R, Hasan A.
- The role of a clinical pharmacist in an integrated heart and vascular clinic – Waddles M, Mitchell G, Snider M, Go M, Attar T
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are tolerated in patients with self-reported statin intolerance in an outpatient lipid clinic – Davidson E, Snider M, Bartsch K, Hirsch A, Larry J
- Pharmacist utilization and impact in a physician-owned, non-academic primary care medical group – Rihtarchik L, Snider M, Steginsky A, Blosser L, VanMeter E, Stone R, Skomorowski M
- Safety of twice daily sotalol in patients with renal impairment -Rabatin A, Snider M, Boyd JM, Peng J, Houmsse M
- Adverse events associated with niacin in patients treated in an outpatient lipid clinic – Albro EA, Hirsch AE, Yildiz VO, Gulati M, Snider M
- Patient portals in pharmacist-run ambulatory care clinics: Is there “Meaningful Use” – Stewart P, Snider M, Bartsch K, Weiss R
- Evaluating the impact of a medication therapy management clinic for outpatients within an academic medical center heart hospital – Schultz A, Vinh D, Jordan T, Bush C, Snider M
- The Effect of GLP-1 Receptor Agonists on Targets for Cardiovascular Risk Reduction – Westrick C, Snider M, Arradaza N, Sharma K
Benefits and Additional Requirements
Application Deadline: January 4
Start Date: July 1
Annual Salary – $48,500
Vacation Days – 10 days
Staffing Requirement – 17 weekends per year
Completion of a Major Research Project